SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
企業コードSINT
会社名SINTX Technologies Inc
上場日Feb 11, 2014
最高経営責任者「CEO」Olson (Eric K)
従業員数20
証券種類Ordinary Share
決算期末Feb 11
本社所在地1885 West 2100 Street
都市SALT LAKE CITY
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号84119
電話番号18018393516
ウェブサイトhttps://sintx.com/
企業コードSINT
上場日Feb 11, 2014
最高経営責任者「CEO」Olson (Eric K)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし